During the last 30 years, the incidence of oesophageal adenocarcinoma has increased rapidly.

Methods: Consecutive patients with oesophageal adenocarcinoma who underwent PET-CT before neoadjuvant chemotherapy and resection were included.

Patients with Barrett's oesophagus have an increased risk of developing oesophageal adenocarcinoma and should be kept under surveillance.

There are few epidemiological data on the dietary risk factors of Barrett's oesophagus, a precursor of oesophageal adenocarcinoma.

The incidence of oesophageal adenocarcinoma (EADC) is rapidly increasing in Western countries and obesity is thought to be a major risk factor.

Incidence rates for adenocarcinoma of the esophagus and gastric cardia have been rising rapidly.

Methods and materials: Patients with adenocarcinoma of the esophagus without distant organ metastases were eligible.

Incidence increased for several cancers, including pancreas, kidney, and adenocarcinoma of the esophagus, which are associated with excess weight.

Patients and methods: Sixty-one patients with advanced, surgically unresectable, or metastatic squamous cell or adenocarcinoma of the esophagus were treated.

A retrospective analysis should compare the two operative approaches, transhiatal or transthoracic resection in patients suffering from adenocarcinoma of the esophagus.

Barrett's esophagus is an important step in the pathway to esophageal adenocarcinoma.

Context: The incidence of esophageal adenocarcinoma is rising and has surpassed squamous cell carcinoma.

Future studies of trastuzumab in esophageal adenocarcinoma are indicated.

Barrett's esophagus (BE) is the principal risk factor for esophageal adenocarcinoma.

Barrett's esophagus is the precursor lesion for esophageal adenocarcinoma.